Initial treatment of uninsured patients with ST-elevation myocardial infarction by facility percutaneous coronary

Sara Lin1, Andrew Shermeyer2, Sayeh Nikpay2

  • 1Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Insights

Uninsured patients with ST-elevation myocardial infarction (STEMI) are less likely to receive initial treatment at PCI-capable facilities. This suggests potential disparities in accessing timely, high-quality STEMI care for the uninsured.

Area of Science:

  • Cardiology
  • Health Services Research
  • Health Equity

Background:

  • Timely reperfusion is critical for reducing morbidity and mortality in ST-elevation myocardial infarction (STEMI).
  • Facilities with percutaneous coronary intervention (PCI) capabilities are essential for rapid reperfusion in STEMI cases.
  • Understanding factors influencing initial care access is vital for improving STEMI outcomes.

Purpose of the Study:

  • To investigate the association between insurance status and initial emergency department (ED) care at PCI-capable facilities for adult STEMI patients.
  • To identify potential disparities in access to time-sensitive STEMI treatments based on insurance coverage.

Main Methods:

  • Retrospective cross-sectional study using California's Department of Healthcare Access and Information database (2011-2019).
  • Included adult patients with STEMI (International Classification of Diseases codes).
  • Multivariable logistic regression analyzed the primary outcome (initial care by PCI-capable facility) with insurance status as the primary exposure, controlling for patient, facility, and temporal factors.

Main Results:

  • Analysis of 135,358 eligible STEMI visits.
  • Uninsured patients had significantly lower odds of initial treatment at PCI-capable facilities (adjusted odds ratio 0.62, 95% CI 0.54-0.72, p < 0.001).
  • Results remained consistent across sensitivity analyses.

Conclusions:

  • Uninsured patients with STEMI are less likely to receive initial care at PCI-capable facilities.
  • Findings indicate potential disparities in accessing high-quality, time-sensitive STEMI treatment for uninsured individuals.
  • Further research and interventions are needed to address these access gaps.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
28
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9